(NASDAQ: CVRX) Cvrx's forecast annual revenue growth rate of 42.85% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.37%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.6%.
Cvrx's revenue in 2024 is $39,295,000.On average, 3 Wall Street analysts forecast CVRX's revenue for 2024 to be $1,161,195,971, with the lowest CVRX revenue forecast at $1,151,443,650, and the highest CVRX revenue forecast at $1,174,045,597. On average, 3 Wall Street analysts forecast CVRX's revenue for 2025 to be $1,626,147,326, with the lowest CVRX revenue forecast at $1,609,342,360, and the highest CVRX revenue forecast at $1,659,568,910.
In 2026, CVRX is forecast to generate $2,259,671,539 in revenue, with the lowest revenue forecast at $2,200,132,150 and the highest revenue forecast at $2,319,210,928.